Overview


According to FutureWise analysis the market for Adrenocortical Hormones API  is expected to reach US$ 3.9 billion by 2031 at a CAGR of 6.82%.

Adrenocortical hormones, an essential group of steroid hormones originating from the adrenal cortex, play intricate and indispensable roles in maintaining the body's complex physiological equilibrium. These hormones orchestrate a symphony of functions that impact metabolism, immune response, electrolyte balance, and stress adaptation. Cortisol, often termed the "stress hormone," is a prominent member of this hormone ensemble. Its secretion is tightly regulated by the hypothalamus-pituitary-adrenal (HPA) axis and responds to various stressors, be they physical, emotional, or metabolic. Cortisol's multifaceted actions include promoting the release of glucose into the bloodstream, enhancing tissue sensitivity to other hormones, suppressing inflammation, and modulating immune responses. This hormone's ability to redirect resources and bolster energy reserves during stress is pivotal for survival. The Active Pharmaceutical Ingredient (API) is the bioactive substance within a drug product (such as a tablet, capsule, cream, or injectable) that induces the desired therapeutic effects.

Aldosterone, another vital adrenocortical hormone, is instrumental in fine-tuning the body's fluid and electrolyte balance. Operating primarily in the kidneys, aldosterone stimulates sodium reabsorption and potassium excretion. This meticulous control of electrolytes helps regulate blood pressure, overall fluid levels, and proper nerve and muscle function. Intricately intertwined within these functions is the body's response to stress and capacity to maintain equilibrium. The adrenal cortex orchestrates these hormones' release in response to various stressors, ensuring the body can adapt and cope effectively. This orchestration extends to regulating metabolic processes and immune reactions and preserving homeostasis despite challenges. Essentially, adrenocortical hormones act as the body's conductors, guiding and harmonizing complex functions to ensure optimal health and well-being. Their intricate choreography is a testament to the body's remarkable ability to navigate diverse stressors and uphold a delicate balance within a dynamic internal environment.

FutureWise Market Research has published a report that provides an insightful analysis of Adrenocortical Hormones API Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Adrenocortical Hormones API Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Pfizer CentreOne
  • Sun Pharmaceutical
  • Tianjin Pharmaceutical Group Co., Ltd.
  • Sanofi
  • Symbiotec Pharmalab
  • GlaxoSmithKline
  • Hovione
  • Guangdong VTR Bio-Tech Co., Ltd
  • Xianju Pharma
  • Cipla
  • Great Pacific Exports
  • Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
  • Shandong Xinhua Pharmaceutical Company Limited
  • Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
  • Shanghai New Hualian Pharmaceutical Co., Ltd

(Note: The list of the major players will be updated with the latest market scenario and trends)

The Adrenocortical Hormones API Market is propelled by several drivers while presenting diverse opportunities and constraints. The escalating prevalence of endocrine disorders, including adrenal insufficiency and Addison's disease, is a significant driver, fostering demand for adrenocortical hormones API for therapeutic interventions. Advancements in drug formulations and delivery methods create avenues for improved treatments. The aging population contributes to market growth due to its increased vulnerability to hormonal imbalances. Furthermore, heightened awareness and diagnostic capabilities facilitate early detection and treatment, positively impacting market demand. Opportunities lie in personalized medicine, where genomic insights enable tailored adrenocortical hormone therapies. Emerging markets, characterized by growing healthcare infrastructure and awareness, offer untapped growth potential. Exploring combination therapies and innovative drug delivery methods further enhances the market landscape. However, challenges encompass stringent regulatory processes, potential side effects and safety concerns, limited awareness and diagnosis in certain regions, high development costs, and competition from alternative treatments. Balancing these factors, stakeholders navigate a dynamic market landscape driven by medical advancements, regulatory dynamics, and evolving patient needs.

By Product Type

  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • Others

By Application

  • Injectable Drugs
  • Oral Drugs
  • For External Use Drugs
  • Inhalation Drugs

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The North American adrenocortical hormones API market is expanding due to the region's growing urbanization and industrialization, which has heightened opportunities across various sectors. This area stands as the largest consumer of the product, thus propelling market growth. A key driver behind the increasing market share of adrenocortical hormones API is the growing demand fueled by heightened pharmaceutical investments and FDA approvals. Moreover, the rising need for injectable drugs, medical facilities, and related services supports the market's expansion. Embracing technological advancements is poised to provide an additional boost to the overall market outlook.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Adrenocortical Hormones API Market By Product Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Adrenocortical Hormones API Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Adrenocortical Hormones API Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Adrenocortical Hormones API Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Adrenocortical Hormones API Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Prednisone Series
        2. Dexamethasone Series
        3. Betamethasone Series
        4. Hydrocortisone Series
        5. Others

  • 8.   Global Adrenocortical Hormones API Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Injectable Drugs
        2. Oral Drugs
        3. For External Use Drugs
        4. Inhalation Drugs

  • 9.   North America Adrenocortical Hormones API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Adrenocortical Hormones API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Adrenocortical Hormones API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Adrenocortical Hormones API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer CentreOne
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Sun Pharmaceutical
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Tianjin Pharmaceutical Group Co., Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Sanofi
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Symbiotec Pharmalab
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. GlaxoSmithKline
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Hovione
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Guangdong VTR Bio-Tech Co., Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Xianju Pharma
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cipla
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Great Pacific Exports
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Shandong Xinhua Pharmaceutical Company Limited
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Shanghai New Hualian Pharmaceutical Co., Ltd
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients